+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Diagnostic Contract Manufacturing Market Size, Share and Growth Outlook, 2026: Analysis By Device (In Vitro Diagnostic , Diagnostic Imaging Devices, Point-of-Care , Handheld and Wearable Diagnostic Monitors), By Service Type (Device Development & Precision Engineering, Component and Assay Manufacturing, Quality Management, Regulatory Compliance & Testing Services, Packaging, Labeling & Final Assembly), By Application Area (Infectious Diseases & Virology, Oncology and Cancer Screening, Cardiology and Vascular Monitoring, Diabetes and Endocrinology, Neurology, Orthopedics, and Gastroenterology), By Target Customer (Medical Device Original Equipment Manufacturers , Biotechnology and Pharmaceutical Startups, Academic, Research, and Institutional Centers) Companies, and Country Forecast, 2021 to 2034

Global Diagnostic Contract Manufacturing Market size is forecast to increase from $37.69 Billion in 2026 to $77.33 Billion in 2034 at a CAGR of 9.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006787
Pages: 221 Pages

Diagnostic Catheter Market Size, Share and Growth Outlook, 2026: Analysis By Product Category (Angiography Catheters, Electrophysiology , Ultrasound Catheters, Optical Coherence Tomography , Pressure and Hemodynamic Monitoring Catheters, Temperature Monitoring Catheters, Specialty & Intravenous Catheters), By Device Type (Diagnostic Imaging Catheters, Non-Imaging Diagnostic Catheters), By Clinical Application (Cardiology and Vascular Interventions, Neurology and Neurovascular Procedures, Urology, Gastroenterology, Oncology and Other Systemic Specialties), By End-User Facility (Hospitals and Fixed Catheterization Laboratories , Independent Imaging and Diagnostic Centers, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Diagnostic Catheter Market size is forecast to increase from $6.1 Billion in 2026 to $10.64 Billion in 2034 at a CAGR of 7.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006786
Pages: 225 Pages

Diabetic Retinopathy Market Size, Share and Growth Outlook, 2026: Analysis By Disease Type (Non-Proliferative Diabetic Retinopathy , Proliferative Diabetic Retinopathy ), By Management (Anti-VEGF Injections, Intraocular Steroid , Laser Photocoagulation Surgery, Vitrectomy Procedures), By Patient Age Demographics (Under 40 Years, 40 to 64 Years, 65 Years and Above), By End-User Facility (General Hospitals and Multi-Specialty Clinics, Specialized Ophthalmology Centers and Retinal Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Diabetic Retinopathy Market size is forecast to increase from $10.86 Billion in 2026 to $18.11 Billion in 2034 at a CAGR of 6.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006785
Pages: 214 Pages

Diabetic Nephropathy Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Angiotensin-Converting Enzyme , Angiotensin II Receptor Blockers , Sodium-Glucose Cotransporter 2 , Mineralocorticoid Receptor Antagonists , Calcium Channel Blockers and Diuretics, Emerging Molecules), By Disease Progression (Hyperfiltration , Micro-Albuminuria , Macro-Albuminuria , Chronic Kidney Disease , End-Stage Renal Disease ), By Route of Administration (Oral Administration, Parenteral Administration ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Drug Stores, Online ), By End-User Facility (Hospitals and Clinics, Specialty Nephrology and Dialysis Centers, Ambulatory and Home Care Settings) Companies, and Country Forecast, 2021 to 2034

Global Diabetic Nephropathy Market size is forecast to increase from $10.59 Billion in 2026 to $15.53 Billion in 2034 at a CAGR of 4.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006784
Pages: 215 Pages

Diabetic Macular Edema (DME) Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Drug Type (Anti-VEGF Therapy , Corticosteroid Therapies , Non-Steroidal Anti-Inflammatory Drugs ), By Treatment Modality (Intravitreal Injections, Intravitreal Implants , Laser Photocoagulation, Combination Therapy), By End User (Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Diabetic Macular Edema (DME) Treatment Market size is forecast to increase from $5.79 Billion in 2026 to $7.57 Billion in 2034 at a CAGR of 3.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006783
Pages: 221 Pages

Diabetic Ketoacidosis (DKA) Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Treatment Type (Insulin Therapy , Fluid Replacement Therapy , Electrolyte Replacement Therapy ), By Application (Adult Diabetic Ketoacidosis, Pediatric Diabetic Ketoacidosis), By End User (Hospitals and Emergency Departments, Intensive Care Units , Ambulatory Care Centers, Specialty Clinics) Companies, and Country Forecast, 2021 to 2034

Global Diabetic Ketoacidosis (DKA) Treatment Market size is forecast to increase from $987.55 Million in 2026 to $1417.35 Million in 2034 at a CAGR of 4.62% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006782
Pages: 212 Pages

Diabetic Foot Ulcer (DFU) Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Wound Care Dressings , Biologics , Therapy Devices , Antibiotic Medications ), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, Neuro-ischemic Ulcers), By End User (Hospitals, Specialized Wound Care Clinics, Ambulatory Surgical Centers , Homecare Settings) Companies, and Country Forecast, 2021 to 2034

Global Diabetic Foot Ulcer (DFU) Treatment Market size is forecast to increase from $6.8 Billion in 2026 to $11.95 Billion in 2034 at a CAGR of 7.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006781
Pages: 222 Pages

Diabetic Eye Disease Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product (Diagnostic & Screening Devices , Therapeutic & Surgical Devices ), By Target Disease Indication (Diabetic Retinopathy , Diabetic Macular Edema , Neovascular Glaucoma, Diabetes-Induced Cataracts), By Technology Platform (Traditional , AI-Enabled and Digital Software Integrated Systems), By End-User Facility (Specialized Eye Hospitals and Ophthalmology Clinics, General Hospitals and Tertiary Care Centers, Ambulatory Surgical Centers , Diagnostic Imaging Centers) Companies, and Country Forecast, 2021 to 2034

Global Diabetic Eye Disease Devices Market size is forecast to increase from $1063.73 Million in 2026 to $1998.25 Million in 2034 at a CAGR of 8.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006780
Pages: 213 Pages

Diabetes Management Supplements Market Size, Share and Growth Outlook, 2026: Analysis By Ingredient Classification (Herbal Extracts and Botanicals, Vitamins and Minerals, Amino Acids and Antioxidants, Omega-3 Fatty Acids and Dietary Fibers, Probiotics), By Product Type (Multi-Ingredient Combination Supplements, Single-Ingredient Supplements), By Source Origin (Plant-Based Ingredients, Animal-Based Ingredients, Synthetic ), By Formulation Format (Capsules and Softgels, Tablets, Powders and Granules, Liquids and Syrups), By Distribution Channel (Offline Channels , Online Channels) Companies, and Country Forecast, 2021 to 2034

Global Diabetes Management Supplements Market size is forecast to increase from $8.4 Billion in 2026 to $16.04 Billion in 2034 at a CAGR of 8.42% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006779
Pages: 228 Pages

Diabetes Management Devices Market Size, Share and Growth Outlook, 2026: Analysis By Device Type (Monitoring Devices , Management & Delivery Devices ), By Target Indication (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By Distribution Channel (Institutional Sales , Retail Pharmacies and Drug Stores, Online ), By Patient Care Setting (Self-Home Healthcare Settings, Hospitals and Specialty Diabetes Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Diabetes Management Devices Market size is forecast to increase from $36.79 Billion in 2026 to $66.6 Billion in 2034 at a CAGR of 7.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006778
Pages: 214 Pages